Hologic is acquiring molecular diagnostics firm Mobidiag Oy in an approximately $795 million deal that will give the women’s health company the capability to offer testing closer to patients with ...

Marlborough medical technology firm Hologic Inc. reported a 74.6% revenue decrease for its COVID-19 related diagnostics testing in its third quarter as compared to last year, indicating a significant ...

Hologic, Inc. HOLX recently announced the receipt of the FDA’s Emergency Use Authorization (EUA) for its Aptima SARS-CoV-2 assay, which can be used to detect SARS-CoV-2, the virus causing coronavirus.

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that it has validated use of its Aptima® and Panther Fusion® molecular diagnostic COVID-19 assays with pooled patient ...

After reaping a windfall from COVID-19 diagnostic demand, Hologic’s spending spree continues with its largest acquisition yet: It’s claimed Mobidiag, the Finnish-French molecular test maker, with a ...

Despite the potential for declining COVID-19 testing revenues on the horizon, Hologic is upping its revenue forecasts for the year—built in part on the back of the M&A deals it closed last year using ...

Hologic's Panther system, pictured here, will be used in a pilot program for a global initiative to expand testing for HIV and another diseases. PHOTO COURTESY Marlborough medical imaging device firm ...

-- Only High-Throughput System to Enable Simultaneous Testing for SARS-CoV-2 and Other Common Respiratory Viruses, Boosting Efficiency and Increasing Clinical Insight -- MARLBOROUGH, Mass.--(BUSINESS ...

Monday - Friday, 6:00 - 7:00 PM ET "We've clearly gotten a big bump up from our Covid testing," Hologic CEO Steve Macmillan told CNBC. Macmillan said the diagnostics company distributed 372 Panther ...